Elliott L Fineman

Title: Innovations of Elliott L Fineman

Introduction

Elliott L Fineman is a notable inventor based in Kensington, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of steroid compounds. With a total of 2 patents, his work focuses on innovative methods for treating various medical conditions.

Latest Patents

Fineman's latest patents include a liposome formulation of 5 β steroids and a formulation for the administration of steroid compounds. The first patent describes liposome preparations that comprise a lipid or lipid-like compound and a 5 β steroid, such as DHEA or an organic acid derivative. These liposomes may also include an entrapped aqueous portion containing the expression product of the ob gene. The methods claimed in this patent aim to treat conditions such as obesity, hypercorticoidism, and diabetes using these liposome preparations. The second patent discloses compositions that include at least one 5 β steroid and an amorphous cyclodextrin. It also outlines methods for treating conditions like obesity, diabetes syndrome, and anemia by administering a composition that contains an effective amount of the steroid and cyclodextrin.

Career Highlights

Elliott L Fineman has been associated with Supergen, Inc., where he has contributed to the development of innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of various health conditions through his patented formulations.

Collaborations

Fineman has collaborated with notable colleagues such as Joseph Rubinfeld and Julius A Vida, enhancing the impact of his work in the field of pharmaceutical innovations.

Conclusion

Elliott L Fineman's contributions to the field of pharmaceutical formulations through his patents demonstrate his commitment to advancing medical treatments. His innovative approaches continue to influence the industry and improve patient outcomes.